BRUSSELS (Reuters) - Belgium has decided to temporarily ban the use of Novo Nordisk (CSE:NOVOb)'s diabetes drug Ozempic as a weight loss treatment amid a shortage of the medicine, according to a royal decree published in the count
https://www.reddit.com/r/darksideofwo/comments/18dzk69/calculator_is_superior_duh/
https://youtube.com/live/2BxSurOqeG4?feature=share